Skip to main content

and
  1. Article

    Open Access

    Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine

    Prostatic acid phosphatase (PAP) is a prostate tumor antigen, and the target of the only FDA-approved anti-tumor vaccine, sipuleucel-T. We have previously reported in two clinical trials that a DNA vaccine enc...

    Ellen Wargowski, Laura E. Johnson, Jens C. Eickhoff in Journal for ImmunoTherapy of Cancer (2018)